- Page 2:
Review of<
- Page 5 and 6:
ACKNOWLEDGMENT The Research Triangl
- Page 8 and 9:
PREFACE Inhaling psychotropic subst
- Page 10 and 11:
Perhaps society can begin to look o
- Page 12 and 13:
Mr. Joseph P. Nachtman Graduate Res
- Page 14 and 15:
CONTENTS (con.) Danger to Self and
- Page 16 and 17:
CONTENTS (con.) Acute Toxicity <str
- Page 18 and 19:
CONTENTS (con.) Chapter 11 Nervous
- Page 20:
CONTENTS (con.) Areas of</s
- Page 23 and 24:
Chapter 1 INHALANT ABUSE: AN OVERVI
- Page 25 and 26:
A special group of
- Page 27 and 28:
intoxication. Industrial workers ar
- Page 29 and 30:
most common complaints noted during
- Page 31 and 32:
SUMMARY Inhalant abuse, a youthful
- Page 34 and 35:
SOCIOCULTURAL-EPIDEMlOlOGlCAL ASPEC
- Page 36 and 37:
use of mind alteri
- Page 38 and 39:
2. Another reason is the nature <st
- Page 40 and 41:
Rates for inhalant use are on about
- Page 42 and 43:
with Indians, and blacks also are m
- Page 44 and 45:
Chambers, C., J. Inciardi, H. Siega
- Page 46 and 47:
Appendix SUMMARY OF EXPLORATORY STU
- Page 48:
New York Miami Louisville Los Angel
- Page 51 and 52:
Chapter 3 CLINICAL EVALUATION OF PS
- Page 53 and 54:
peer ratings of re
- Page 55 and 56:
The literature generally provides l
- Page 57 and 58:
MENTAL STATUS OF USERS Cognitive Di
- Page 59 and 60:
Tinklenberg and Woodrow (1974) cont
- Page 61 and 62:
Psychotic Organic Brain Syndrome (O
- Page 63 and 64:
Beer Marihuana Spray paint Liquor G
- Page 65 and 66:
Lachar and his colleagues (in press
- Page 67 and 68:
work setting while providing for an
- Page 69 and 70:
2. sniffing, unobtrusive or nonreac
- Page 71 and 72:
De la Garza, F., I. Mendiola, and S
- Page 73 and 74:
Maletzky, B. Assisted covert sensit
- Page 75 and 76:
MEDICAL EVALUATION OF INHALANT ABUS
- Page 77 and 78:
are not actively avoided. Table 1 s
- Page 79 and 80:
TABLE 1 SUMMARY OF CLINICAL SYNDROM
- Page 81 and 82:
TABLE 1 SUMMARY OF CLINICAL SYNDROM
- Page 83 and 84:
TABLE 1 SUMMARY OF CLINICAL SYNDROM
- Page 85 and 86:
TABLE 1 SUMMARY OF CLINICAL SYNDROM
- Page 87 and 88:
Aerosols Abuse of
- Page 89 and 90:
either peripheral neuropathy or myo
- Page 91 and 92:
DATA SUMMARY Table 2 summarizes the
- Page 93 and 94:
Ear disease Nose, sinus, throat Fai
- Page 95 and 96:
over-the-counter drugs or use <stro
- Page 97 and 98:
The patient is asked to stand, to w
- Page 99 and 100:
Bass, M. Sudden sniffing death. JAM
- Page 101 and 102:
Storms, W. Chlorof
- Page 103 and 104:
(Taher et al., 1974), permanent adv
- Page 105 and 106:
during the course of</stron
- Page 107 and 108:
abuser, particular attention would
- Page 109 and 110:
Reinhardt, C., A. Azar, M. Maxfield
- Page 111 and 112:
NEUROLOGICAL HISTORY A. Record onse
- Page 113 and 114:
NEUROLOGICAL EXAMINATION (Items to
- Page 115 and 116:
VII. FACIAL MOTOR (VOLITIONAL, EMOT
- Page 117 and 118:
E. SENSORY: Chart deficits in: Pain
- Page 119 and 120:
Chapter 6 INTRODUCTION Daniel Couri
- Page 121 and 122:
TABLE 1 OCCURRENCES OF VOLATILE SUB
- Page 123 and 124:
Chapter 7 ABUSE OF INHALATION ANEST
- Page 125 and 126:
GASES Name Nitrous Oxide Ethylene C
- Page 127 and 128:
Generic Name Trade Nitrous Oxide No
- Page 129 and 130:
INCIDENCE AND CONTROL OF ANESTHETIC
- Page 131 and 132:
Deniker, P., M. Cottereau, H. Lôo,
- Page 133 and 134:
Chapter 8 TOXlCOLOGY OF ALCOHOLS, K
- Page 135 and 136:
The time course of
- Page 137 and 138:
TABLE 1 ACUTE TOXICITY OF ALCOHOLS
- Page 139 and 140:
Industrial exposure to ketones occu
- Page 141 and 142:
Despite widespread use of</
- Page 143 and 144:
It has been shown that methyl ethyl
- Page 145 and 146:
Chapter 9 TOXICOLOGY OF ALIPHATIC A
- Page 147 and 148:
percent of an oral
- Page 149 and 150:
individuality in resistancce to ben
- Page 151 and 152:
to intoxicate himself within 1 to 3
- Page 153 and 154:
Organ Toxicity Animal. Toxicity stu
- Page 155 and 156:
1961). The threshold limit value fo
- Page 157 and 158:
imately 3 percent of</stron
- Page 159 and 160:
several intermediates to 1,2-dihydr
- Page 161 and 162:
n-Hexante n-Hexane (CH 3(CH 2) 4CH
- Page 163 and 164:
toxicity. Frommer et al. (1974) not
- Page 165 and 166:
gests that death may result in some
- Page 167 and 168:
incoordination, prostration, and co
- Page 169 and 170:
i.v. the LD 50 was 51 mg/kg Dewey e
- Page 171 and 172:
II. Animal and human response to va
- Page 173 and 174:
Elkins, H. The chemistry of
- Page 175 and 176:
Grant, W. Toxicology of</st
- Page 177 and 178:
exposure with mortality and toluene
- Page 179 and 180:
Nomiyama, K. Studies on poisoning b
- Page 181 and 182:
Reinhardt, C., A. Azar, M. Maxfield
- Page 183 and 184:
Tauber, J. Instant benzol death. J
- Page 185 and 186:
Chapter 10 PRECLINICAL PHARMACOLOGY
- Page 187 and 188:
TABLE 1 INHALATIONAL TOXlCITY OF FL
- Page 189 and 190:
There is no question that methylene
- Page 191 and 192:
In the canine heart-lung preparatio
- Page 193 and 194: is used as a solvent in cosmetic an
- Page 195 and 196: mean aortic pressure, and mean pulm
- Page 197 and 198: Pretreatment of ra
- Page 199 and 200: FC 11 FC 12 Compound Carbon tetrach
- Page 201 and 202: National I
- Page 203 and 204: Their toxicity and potential danger
- Page 205 and 206: Zakhari, S., and D. Aviado. Cardiop
- Page 207 and 208: include photophobia, irritation <st
- Page 209 and 210: compound or of ano
- Page 211 and 212: portions of the sc
- Page 213 and 214: chicken, cat, rat, and mouse. The k
- Page 215 and 216: The combined solvents encountered i
- Page 217 and 218: CONCLUDING REMARKS Little is known
- Page 219 and 220: Saida. K, J. Mendell, and H. Weiss.
- Page 221 and 222: Chapter 12 PRECLINICAL BEHAVIORAL T
- Page 223 and 224: The squirrel monkey has been shown
- Page 225 and 226: dependency. It may be possihle to i
- Page 227 and 228: spectrum of solven
- Page 229 and 230: without adverse effects. Threshold
- Page 231 and 232: espiratory arrest at higher concent
- Page 233 and 234: ear problems (Patterson and Bartlet
- Page 235 and 236: Ishikawa and Schmidt (1973) noted t
- Page 237 and 238: statistically significant, it is di
- Page 239 and 240: The very early age at which solvent
- Page 241 and 242: Bushnell P., P. Malof</stro
- Page 243: Parkhouse, J., J. Henrie, G. Duncan
- Page 247 and 248: Chapter 13 APPROACHES TO THE PROBLE
- Page 249 and 250: these additive substances? Would th
- Page 251 and 252: Another form of re
- Page 253 and 254: to date comes from psychiatric: eme
- Page 255 and 256: inhalant users among those Indian y
- Page 257 and 258: that they do not carefully evaluate
- Page 259 and 260: Impairments First, the type, onset,
- Page 261 and 262: Evaluation of mixt
- Page 263 and 264: mixtures and relate their toxicity
- Page 265 and 266: This bibliography contains all refe
- Page 267 and 268: . Combination of g
- Page 269 and 270: Anonymous. Don’t get killed by a
- Page 271 and 272: Anonymous. Product Safety Commissio
- Page 273 and 274: . Toxicity of aero
- Page 275 and 276: Banks, A., A. Campbell, and A. Rudg
- Page 277 and 278: . GlomeruIonephritis associated wit
- Page 279 and 280: Blumberg, H., and H. Herbert. Surve
- Page 281 and 282: Brody, R., T. Watanabe, and D. Avia
- Page 283 and 284: Carlton, R. Fluorocarbon toxicity:
- Page 285 and 286: Cherkin, A. Mechanisms of</
- Page 287 and 288: Cooke, J., and S. Beard. Speech int
- Page 289 and 290: Cyran, J. [Symptoms and differentia
- Page 291 and 292: De Rosa, E., B. Saia, and E. Bet. [
- Page 293 and 294: Downing, R., and D. Madinabertia. T
- Page 295 and 296:
Elliott, H. Effects of</str
- Page 297 and 298:
Flek, J., and V. Sedivec. Determina
- Page 299 and 300:
. Exposure to white spirit. II. Psy
- Page 301 and 302:
Glogowska, M., and J. Widdicombe. T
- Page 303 and 304:
Grunewald, A., and G. John. [The ef
- Page 305 and 306:
Hattori, S., R. Tateishi, T. Horai,
- Page 307 and 308:
Holsten, F. Flashbacks: A personal
- Page 309 and 310:
Imamura, T., and M. Ikeda. Lower fi
- Page 311 and 312:
Johnstone, M. Letter: Nitrous oxide
- Page 313 and 314:
Kazmina, N. Study of</stron
- Page 315 and 316:
Kojima, R. Effect of</stron
- Page 317 and 318:
Kubic, V., and M. Anders. Metabolis
- Page 319 and 320:
Larsen, L. Occupational health case
- Page 321 and 322:
Lipton, D. A survey of</str
- Page 323 and 324:
Magos, L., W. Butler, I. White, and
- Page 325 and 326:
McKenna, E., and R. Kallio. The bio
- Page 327 and 328:
Molloy, M., I. Latto, and M. Rosen.
- Page 329 and 330:
Murray, A., and J. Riley. Occurrenc
- Page 331 and 332:
. Respiratory retention, uptake and
- Page 333 and 334:
Ostapenko, O., and V. Kustov. Evalu
- Page 335 and 336:
Philbin, D., and E. Lowenstein. Lac
- Page 337 and 338:
Przybylowski, J. [Current views on
- Page 339 and 340:
Richards, C. Does trichloroethylene
- Page 341 and 342:
Sackner, M., S. Epstein, and A. Wan
- Page 343 and 344:
Sawyer, D., and E. Eger, II. Hepati
- Page 345 and 346:
Schwetz, B., B. Leong, and P. Gehri
- Page 347 and 348:
Shuzaev, V. Toxic action of
- Page 349 and 350:
Smith, H. Inhalation of</st
- Page 351 and 352:
Stewart, R., C. Hake, and J. Peters
- Page 353 and 354:
Szadkowski, D., R. Pett, J. Angerer
- Page 355 and 356:
. Combined effects of</stro
- Page 357 and 358:
Toy, P., E. Van Stee, A. Harris, M.
- Page 359 and 360:
Ulanova, I., G. Avilova, N. Maltsev
- Page 361 and 362:
Vigliani, E. Leukemia associated wi
- Page 363 and 364:
Weinstein, R., D. Boyd, and K. Back
- Page 365 and 366:
Yanagawa, F., and T. Fujita. [Conce
- Page 367 and 368:
While limited supplles last, single
- Page 369 and 370:
17 RESEARCH ON SMOKING BEHAVIOR. Mu
- Page 371 and 372:
36 NEW APPROACHES TO TREATMENT OF C
- Page 373 and 374:
51 DRUG ABUSE TREATMENT EVALUATION: